Stem Cell–Derived Islets: Next Steps for Histologic and Functional Assessment During Development as a Cellular Therapy for the Treatment of Diabetes
- Michael R. Rickels⇑
- Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, and Institute for Diabetes, Obesity & Metabolism, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
- Corresponding author: Michael R. Rickels, rickels{at}pennmedicine.upenn.edu
Article Information
vol. 68 no. 5 901-903
PubMed
Published By
Print ISSN
Online ISSN
History
- Published in print April 22, 2019.
Copyright & Usage
© 2019 by the American Diabetes Association. http://www.diabetesjournals.org/content/licenseReaders may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.
Author Information
- Michael R. Rickels⇑
- Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, and Institute for Diabetes, Obesity & Metabolism, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA
- Corresponding author: Michael R. Rickels, rickels{at}pennmedicine.upenn.edu
Statistics from Altmetric.com
Article usage
In this Issue
May 2019, 68(5)
Stem Cell–Derived Islets: Next Steps for Histologic and Functional Assessment During Development as a Cellular Therapy for the Treatment of Diabetes
